Categories: CEOs

Drugmaker Chooses Lone Wolf Strategy

Posted by: Arlene Weintraub on October 07

On October 6, shares of pharmaceutical startup MannKind Corp. plummeted 30% to $6.30, when the company predicted it wouldn't sign a partnership deal with a well-capitalized Big Pharma company until...

CEO Turnover: A Sign of Recovery?

Posted by: Jena McGregor on October 01

It's been a week of changes at the top, with the number of major companies announcing succession plans, CEO resignations or departures mounting by the day. Under fire at the...

Garth Drabinsky Gets Seven Years in Prison

Posted by: Diane Brady on August 05

At this point, many people will have forgotten the tale of Garth Drabinsky. As corporate criminals go, the former theater impresario has neither the decadent streak of a Dennis Kozlowski,...

More Pharma Mergers to Come?

Posted by: Arlene Weintraub on August 04

Rumors that Botox maker and eye-products giant Allergan might be a takeover target pushed the company's shares up 4% on August 3 to $55.55. Among the oft-discussed suitors is...

Lilly CEO Bets on NYC for R&D

Posted by: Arlene Weintraub on July 22

On July 22, Eli Lilly CEO John Lechleiter announced that his company would be the anchor tenant at New York City's brand new biotech research center, called East River...

Pfizer CEO Braces For Changes

Posted by: Arlene Weintraub on July 10

Pfizer's CEO Jeff Kindler stopped by BusinessWeek for lunch yesterday. Before a firing line of reporters and editors, he tackled some tough questions on the company's pending mega-merger with...

Biotech M&A Poised to Soar

Posted by: Arlene Weintraub on June 18

Drug company CEOs will be driven to look for more M&A opportunities, according to a new report from Frost & Sullivan. In the first half of the year alone, Merck...

P&G's New CEO: Business As Usual

Posted by: Roger Crockett on June 10

Okay, it’s finally official. Procter & Gamble confirmed today that renowned chief executive A.G. Lafley will pass the baton to current COO Robert A. McDonald. McDonald takes over July...

CEOs of Tomorrow

Posted by: Matthew Boyle on May 01

In compiling our list of the 25 CEOs of Tomorrow, we spoke with dozens of academics, headhunters, CEOs, directors, and management gurus about what qualities will define those who take...

How will the CEOs of tomorrow be paid?

Posted by: Matthew Boyle on April 23

For our upcoming package on "The CEOs of Tomorrow," one question we wanted to answer was how the economic crisis and the increasing regulatory environment will impact CEO pay packages...

Industry leaders at Davos on new ways to grow

Posted by: Diane Brady on January 30

Strip away talk about the U.S. dollar, the credit crunch and global leaders turning against each other, and one theme has emerged in conversations at Davos: new ideas for growth....

So That's Why They Always Criticize Stock Analysts....

Posted by: Jena McGregor on August 08

It's not surprising, perhaps, but I'm always amused with how many CEOs are quick to criticize stock analysts and their short-term views of their stocks. That may be true, but...